(Q40378717)

20 September 2017

Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy (English)

1 reference

20 September 2017

0 references

0 references

1 reference

1

1 reference

20 September 2017

Zager JS

2

1 reference

20 September 2017

Hezel M

3

1 reference

20 September 2017

Stanziale SF

4

1 reference

20 September 2017

Adusumilli PS

5

1 reference

20 September 2017

Gonen M

6

1 reference

20 September 2017

Ebright MI

7

1 reference

20 September 2017

Culliford A

8

1 reference

20 September 2017

Gusani NJ

9

1 reference

20 September 2017

Fong Y

10

1 reference

20 September 2017

1 March 2006

1 reference

20 September 2017

1 reference

20 September 2017

13

1 reference

20 September 2017

326-334

1 reference

20 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700890

20 September 2017

0 references

cites work

Management Strategies in Resection for Hilar Cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

Palliative and postoperative radiotherapy in biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

Replication-selective herpes simplex virus type 1 mutant therapy of cervical cancer is enhanced by low-dose radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

Gadd34 functional domains involved in growth suppression and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

Activation of Gadd34 by diverse apoptotic signals and suppression of its growth inhibitory effects by apoptotic inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

Mammalian GADD34, an apoptosis- and DNA damage-inducible gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (KMBC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

Biliary adenocarcinoma. Characterisation of three new human tumor cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

Ionizing radiation potentiates the antitumor efficacy of oncolytic herpes simplex virus G207 by upregulating ribonucleotide reductase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

DNA damage-inducible transcripts in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

Myc suppresses induction of the growth arrest genes gadd34, gadd45, and gadd153 by DNA-damaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

7 January 2021

Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

7 January 2021

Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

7 January 2021

In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

7 January 2021

Interleukin 12 secretion enhances antitumor efficacy of oncolytic herpes simplex viral therapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

7 January 2021

Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700890

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700890

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference